A comparison of bolus insulin dose errors based on results of a clinical trial of five blood glucose monitoring systems

2019 ◽  
Vol 10 (12) ◽  
pp. 793-799
Author(s):  
Scott Pardo
Keyword(s):  
Blood Glucose ◽  
Insulin Dose ◽  
Glucose Monitoring ◽  
Blood Glucose Monitoring ◽  
Dose Error ◽  
Dosing Error ◽  
Error Range ◽  
Target Blood Glucose ◽  
Bolus Insulin ◽  
Post Hoc

Aim: Inaccurate blood glucose monitoring system (BGMS) results may lead to insulin dosing errors and adverse clinical outcomes. Results & methodology: This post-hoc analysis used a model to estimate the bolus insulin dose error associated with each of the five BGMSs, for a hypothetical person with diabetes (assuming a standardized meal and target blood glucose of 100 mg/dl). Differences in dose-error distribution between BGMSs were statistically tested. The 95% dose-error range for each BGMS was (insulin units): CONTOUR®PLUS, -1.1–0.7; Accu-Chek® Active, -2.4–0.7; Accu-Chek® Performa, -2.9–0.8; FreeStyle Freedom, from -5.5 to -0.5; OneTouch® SelectSimple™, -4.1−3.0. Conclusion: The CONTOUR®PLUS BGMS was associated with a statistically significantly smaller model-estimated median bolus insulin dose-error and dosing error range, compared with the other BGMSs.

941-P: Frequency of Blood Glucose Monitoring in Relation to Medical Cost and Glycemic Control in Hospitalized Patients with Type 2 Diabetes

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 941-P
Author(s):  
LEI ZHANG ◽  
YAN GU ◽  
YUXIU YANG ◽  
NA WANG ◽  
WEIGUO GAO ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Blood Glucose ◽  
Glycemic Control ◽  
Medical Cost ◽  
Glucose Monitoring ◽  
Hospitalized Patients ◽  
Blood Glucose Monitoring

Do We Need the Replacement of YSI 2300? A View from the Clinical Laboratory

2021 ◽  
pp. 193229682110071
Author(s):  
Loukia Spanou ◽  
Konstantinos Makris
Keyword(s):  
Blood Glucose ◽  
Analytical Method ◽  
Clinical Laboratory ◽  
Glucose Monitoring ◽  
Point Of View ◽  
Blood Glucose Monitoring ◽  
Monitoring Systems ◽  
Comparator Method ◽  
Specific Device ◽  
Overall Performance

In this issue of Journal of Diabetes Science and Technology, Baumstark et al. evaluated the analytical performance of a bench-top laboratory glucose analyzer (SUPER-GL) intended for replacement for the YSI2300-STAT analyzer, that served for several decades as a comparator method in clinical and analytical studies of blood glucose monitoring systems (BGMS). The authors concluded that the SUPER-GL’s overall performance is comparable to that of YSI2300-STAT, and has the potential to be a candidate comparator analyzer. However, the question is if we need to recommend as a “comparator method,” a specific device, that measure glucose using the same analytical method with most BGMS. In this analysis we present our point of view hoping to generate a discussion on the necessity for such a replacement.

Sign in / Sign up

Export Citation Format

Share Document